{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Tasquinimod",
  "nciThesaurus": {
    "casRegistry": "254964-60-8",
    "chebiId": "",
    "chemicalFormula": "C20H17F3N2O4",
    "definition": "A quinoline-3-carboxamide linomide analogue with antiangiogenic and potential antineoplastic activities. Tasquinimod has been shown to decrease blood vessel density but the exact mechanism of action is not known. This agent has also been shown to augment the antineoplastic effects of docetaxel and androgen ablation in a murine model of prostate cancer involving human prostate cancer xenografts.",
    "fdaUniiCode": "756U07KN1R",
    "identifier": "C74080",
    "preferredName": "Tasquinimod",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C129820",
      "C1742"
    ],
    "synonyms": [
      "ABR-215050",
      "TASQ",
      "TASQUINIMOD",
      "Tasquinimod"
    ]
  }
}